Indeed, Ott et al. (91) suggest the importance of metabolomic programming by demonstrating that several metabolites, potentially relevant for the development of the disease, are shared between mothers with GDM and their offspring even several years after delivery, regardless of other factors such as BMI or insulin sensitivity. The gene discussed is INS; the disease is gestational diabetes.